Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents - 100004

Spotlight
Video

Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents

imedex has 1329 videos Subscribe Here

Loading........
Description: In this presentation from "Great Debates and Updates in Hematologic Malignancies 2016", Dr. Paul Barr argues that the optimal treatment for chronic lymphocytic leukemia (CLL) patients with a 17p deletion is the use of a novel agent.

A continuing education program is offered as a supplement to this webcast at the following location:
http://elc.imedex.com/ELC/A...

© 2016 Imedex, LLC.
Shared By : imedex
Posted on : 05/22/16
Added : 3 years ago